Benoît Baron
Janssen (Switzerland)(CH)Johnson & Johnson (Israel)(IL)Janssen (Netherlands)(NL)Johnson & Johnson (Netherlands)(NL)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Radiopharmaceutical Chemistry and Applications, Cancer, Lipids, and Metabolism, Hormonal and reproductive studies, Cancer Treatment and Pharmacology
Most-Cited Works
- → ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer(2019)1,136 cited
- → Final Results of a Randomized Phase III Trial of Sequential High-Dose Methotrexate, Fluorouracil, and Doxorubicin Versus Etoposide, Leucovorin, and Fluorouracil Versus Infusional Fluorouracil and Cisplatin in Advanced Gastric Cancer: A Trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group(2000)533 cited
- → Elevated Serum Cytokines Correlated with Altered Behavior, Serum Cortisol Rhythm, and Dampened 24-Hour Rest-Activity Patterns in Patients with Metastatic Colorectal Cancer(2005)259 cited
- → Phase III Trial Comparing 4-Day Chronomodulated Therapy Versus 2-Day Conventional Delivery of Fluorouracil, Leucovorin, and Oxaliplatin As First-Line Chemotherapy of Metastatic Colorectal Cancer: The European Organisation for Research and Treatment of Cancer Chronotherapy Group(2006)220 cited
- → Implications of circadian clocks for the rhythmic delivery of cancer therapeutics(2007)195 cited